Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Bornstein

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Surgical Oncology|January 1, 1970
An evaluation of the mechanism of action of pentamidine isethionateR S Bornstein, J W Yarbro
Cancer|October 1, 1972
Chronic myelogenous leukemia presenting in blastic crisisR S Bornstein, M Nesbit, B J Kennedy
Annals of Internal Medicine|March 1, 1972
Immunotherapy: the need for critical studiesR S Bornstein, J W Yarbro, R T Prehn
The New England Journal of Medicine|July 29, 1971
Orchiectomy for trophoblastic tumorsR S Bornstein, P F Engstrom, J W Yarbro, et al.
Cancer|November 1, 1975
Comparison of serum concentrations of methotrexate after various routes of administrationM Freeman-Narrod, B J Gerstley, P F Engstrom, et al.
Cancer Research|December 1, 1971
Cytogenetic effects of bleomycin therapy in manR S Bornstein, D A Hungerford, G Haller, et al.
Cancer|February 1, 1976
Intralesional BCG in the treatment of metastatic malignant melanomaM J Mastrangelo, H L Sulit, L M Prehn, et al.
National Cancer Institute Monograph|December 1, 1973
Immunotherapy of melanoma with intralesional BCGR S Bornstein, M J Mastrangelo, H Sulit, et al.
Journal of the National Cancer Institute|January 1, 1974
Clinical and histologic correlation of melanoma regression after intralesional BCG therapy: a case reportM J Mastrangelo, Y H Kim, R S Bornstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22B Fisher, S Anderson, D L Wickerham, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Surgical Oncology|January 1, 1970
An evaluation of the mechanism of action of pentamidine isethionateR S Bornstein, J W Yarbro
Cancer|October 1, 1972
Chronic myelogenous leukemia presenting in blastic crisisR S Bornstein, M Nesbit, B J Kennedy
Annals of Internal Medicine|March 1, 1972
Immunotherapy: the need for critical studiesR S Bornstein, J W Yarbro, R T Prehn
The New England Journal of Medicine|July 29, 1971
Orchiectomy for trophoblastic tumorsR S Bornstein, P F Engstrom, J W Yarbro, et al.
Cancer|November 1, 1975
Comparison of serum concentrations of methotrexate after various routes of administrationM Freeman-Narrod, B J Gerstley, P F Engstrom, et al.
Cancer Research|December 1, 1971
Cytogenetic effects of bleomycin therapy in manR S Bornstein, D A Hungerford, G Haller, et al.
Cancer|February 1, 1976
Intralesional BCG in the treatment of metastatic malignant melanomaM J Mastrangelo, H L Sulit, L M Prehn, et al.
National Cancer Institute Monograph|December 1, 1973
Immunotherapy of melanoma with intralesional BCGR S Bornstein, M J Mastrangelo, H Sulit, et al.
Journal of the National Cancer Institute|January 1, 1974
Clinical and histologic correlation of melanoma regression after intralesional BCG therapy: a case reportM J Mastrangelo, Y H Kim, R S Bornstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22B Fisher, S Anderson, D L Wickerham, et al.
Pageof 1